318 related articles for article (PubMed ID: 33841446)
1. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.
Sinkovits G; Mező B; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
Front Immunol; 2021; 12():663187. PubMed ID: 33841446
[TBL] [Abstract][Full Text] [Related]
2. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
[TBL] [Abstract][Full Text] [Related]
3. Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.
de Nooijer AH; Grondman I; Janssen NAF; Netea MG; Willems L; van de Veerdonk FL; Giamarellos-Bourboulis EJ; Toonen EJM; Joosten LAB;
J Infect Dis; 2021 Feb; 223(2):214-224. PubMed ID: 33038254
[TBL] [Abstract][Full Text] [Related]
4. Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study.
Charitos P; Heijnen IAFM; Egli A; Bassetti S; Trendelenburg M; Osthoff M
Front Immunol; 2021; 12():765330. PubMed ID: 34777382
[TBL] [Abstract][Full Text] [Related]
5. Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality.
Defendi F; Leroy C; Epaulard O; Clavarino G; Vilotitch A; Le Marechal M; Jacob MC; Raskovalova T; Pernollet M; Le Gouellec A; Bosson JL; Poignard P; Roustit M; Thielens N; Dumestre-Pérard C; Cesbron JY
Front Immunol; 2021; 12():742446. PubMed ID: 34567008
[TBL] [Abstract][Full Text] [Related]
6. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
Front Immunol; 2021; 12():716361. PubMed ID: 34491250
[TBL] [Abstract][Full Text] [Related]
7. C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia.
Posch W; Vosper J; Noureen A; Zaderer V; Witting C; Bertacchi G; Gstir R; Filipek PA; Bonn GK; Huber LA; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
J Allergy Clin Immunol; 2021 Jun; 147(6):2083-2097.e6. PubMed ID: 33852936
[TBL] [Abstract][Full Text] [Related]
8. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
Holter JC; Pischke SE; de Boer E; Lind A; Jenum S; Holten AR; Tonby K; Barratt-Due A; Sokolova M; Schjalm C; Chaban V; Kolderup A; Tran T; Tollefsrud Gjølberg T; Skeie LG; Hesstvedt L; Ormåsen V; Fevang B; Austad C; Müller KE; Fladeby C; Holberg-Petersen M; Halvorsen B; Müller F; Aukrust P; Dudman S; Ueland T; Andersen JT; Lund-Johansen F; Heggelund L; Dyrhol-Riise AM; Mollnes TE
Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25018-25025. PubMed ID: 32943538
[TBL] [Abstract][Full Text] [Related]
9. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
10. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
Zinellu A; Mangoni AA
Front Immunol; 2021; 12():696085. PubMed ID: 34163491
[TBL] [Abstract][Full Text] [Related]
11. Complement Activation in Kidneys of Patients With COVID-19.
Pfister F; Vonbrunn E; Ries T; Jäck HM; Überla K; Lochnit G; Sheriff A; Herrmann M; Büttner-Herold M; Amann K; Daniel C
Front Immunol; 2020; 11():594849. PubMed ID: 33584662
[TBL] [Abstract][Full Text] [Related]
12. Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections.
Huber S; Massri M; Grasse M; Fleischer V; Kellnerová S; Harpf V; Knabl L; Knabl L; Heiner T; Kummann M; Neurauter M; Rambach G; Speth C; Würzner R
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960645
[TBL] [Abstract][Full Text] [Related]
13. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
[TBL] [Abstract][Full Text] [Related]
14. Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients.
Barratt-Due A; Pettersen K; Børresdatter-Dahl T; Holter JC; Grønli RH; Dyrhol-Riise AM; Lerum TV; Holten AR; Tonby K; Trøseid M; Skjønsberg OH; Granerud BK; Heggelund L; Kildal AB; Schjalm C; Aaløkken TM; Aukrust P; Ueland T; Mollnes TE; Halvorsen B;
J Intern Med; 2024 Jul; 296(1):80-92. PubMed ID: 38539241
[TBL] [Abstract][Full Text] [Related]
15. Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.
Leatherdale A; Stukas S; Lei V; West HE; Campbell CJ; Hoiland RL; Cooper J; Wellington CL; Sekhon MS; Pryzdial ELG; Conway EM
Med Microbiol Immunol; 2022 Feb; 211(1):37-48. PubMed ID: 35034207
[TBL] [Abstract][Full Text] [Related]
16. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study.
Fang S; Wang H; Lu L; Jia Y; Xia Z
Int Immunopharmacol; 2020 Dec; 89(Pt A):107070. PubMed ID: 33039965
[TBL] [Abstract][Full Text] [Related]
17. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients.
Lage SL; Rocco JM; Laidlaw E; Rupert A; Galindo F; Kellogg A; Kumar P; Poon R; Wortmann GW; Lisco A; Manion M; Sereti I
Front Immunol; 2022; 13():815833. PubMed ID: 35250994
[TBL] [Abstract][Full Text] [Related]
18. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System.
Lipcsey M; Persson B; Eriksson O; Blom AM; Fromell K; Hultström M; Huber-Lang M; Ekdahl KN; Frithiof R; Nilsson B
Front Immunol; 2021; 12():627579. PubMed ID: 33692801
[TBL] [Abstract][Full Text] [Related]
19. Association of Inflammatory Markers with Mortality in COVID-19 Infection.
Arshad AR; Khan I; Shahzad K; Arshad M; Haider SJ; Aslam MJ
J Coll Physicians Surg Pak; 2020 Oct; 30(10):158-163. PubMed ID: 33291195
[TBL] [Abstract][Full Text] [Related]
20. Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.
Henry BM; Szergyuk I; de Oliveira MHS; Lippi G; Benoit JL; Vikse J; Benoit SW
J Med Virol; 2021 Sep; 93(9):5515-5522. PubMed ID: 33974276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
